CD44 and glioblastoma: In contrast with NC-GBM tumors, 2 populations of peripheral CD45hiCD11b+CD14+ MDMs distinguished by expression of CD32, CD44, HLA-DR, CD69, and chemokine receptors CXCR3 and CCR4 were enriched in C-GBM tumors.